Nextremity Solutions, Inc. Announces Commercialization of Intraosseous Fixation Platform for Use in Extremities Share Article I look forward to bringing this treatment option to my patients. WARSAW, Ind. (PRWEB) March 11, 2021 Nextremity Solutions, Inc., a Strategic Commercialization Organization (SCO) with a focus on the extremity musculoskeletal space, located in “The Orthopedic Capital of the World,” Warsaw, Ind., announced that it will begin commercialization efforts of its StealthFix™ intraosseous fixation platform; a novel fixation platform for use in both upper and lower extremities. StealthFix is an intraosseous small bone fixation system for the treatment of arthrodesis, osteotomies and bone fractures. Devices that are currently used in the treatment of these indications are bone plates, staples and screws. The majority of these treatment options are placed on bone. The prominence of these devices has been reported to cause soft tissue irritation, as well as pain in some patients. This typically will lead to removal of the hardware in a subsequent surgery. Intraosseous solutions, such as the StealthFix, are completely implanted within the bone, minimizing complications due to hardware prominence.